Blood plasma serves as a raw material for dozens of life-saving medical products, from clotting treatments for hemophilia to immune therapies for people whose bodies can’t fight infection on their own. It also plays a direct role in emergency medicine, surgical recovery, and a growing number of regenerative treatments. Plasma is about 92% water, with the remaining 8% made up of proteins (albumin, clotting factors, antibodies, and fibrinogen), hormones, vitamins, and electrolytes. Those proteins are what make plasma so valuable.
Treating Bleeding Disorders
One of plasma’s most critical uses is producing clotting factor concentrates for people with hemophilia. Hemophilia A results from the body’s failure to produce factor VIII, while hemophilia B involves a shortage of factor IX. Without these proteins, even minor injuries can cause prolonged, dangerous bleeding. Clotting factors extracted from donated plasma replaced the need for whole blood transfusions and transformed hemophilia from a frequently fatal condition into a manageable one.
Modern plasma fractionation facilities isolate these clotting factors using a combination of cold precipitation and chromatography, a separation technique that targets specific proteins based on their chemical properties. The isolated factors are then treated to kill any viruses before being freeze-dried into a form that can be stored and reconstituted when a patient needs an infusion.
Immune Therapy for Immunodeficiency
Immunoglobulins, the antibodies found in plasma, are pooled from thousands of donors and concentrated into a product used to treat people with primary immunodeficiency. These patients produce little or no antibody on their own, leaving them vulnerable to repeated, severe infections. Regular infusions of donor immunoglobulins give their immune systems the protection they lack.
The scale of this need is staggering. It takes more than 130 individual plasma donations per year to treat a single patient with primary immunodeficiency. Globally, annual plasma demand exceeds 60 million liters, and supply still falls short by several million liters each year. This gap is the main reason plasma donation centers actively recruit donors.
Emergency and Trauma Care
Fresh frozen plasma (FFP) is used in hospitals to treat patients who are bleeding heavily from trauma, surgery, or burns. It contains the full spectrum of clotting proteins and is transfused to restore the blood’s ability to form clots when a patient has lost large volumes of blood. FFP is frozen at minus 18°C or colder within eight hours of collection and has a shelf life of one year.
In burn patients, plasma serves an additional purpose. Severe burns damage the lining of blood vessels, causing fluid to leak out of the bloodstream and into surrounding tissue. Plasma transfusion helps repair that vascular lining and may reduce the total volume of fluid a burn patient needs during resuscitation, which in turn lowers the risk of complications from fluid overload.
Albumin in Liver and Kidney Disease
Albumin is the most abundant protein in plasma, and it’s extracted on a massive scale using an ethanol-based precipitation process first developed in the 1940s. Its primary job in the body is maintaining fluid balance: it keeps water inside blood vessels rather than letting it seep into tissues. When albumin levels drop, fluid accumulates in the abdomen, lungs, and limbs.
This makes albumin infusions essential for patients with advanced liver cirrhosis. A damaged liver can’t produce enough albumin on its own, so fluid builds up in the abdominal cavity. When doctors drain that fluid (a procedure called paracentesis), albumin is given intravenously to prevent the circulatory system from destabilizing. Albumin is also a frontline treatment for hepatorenal syndrome, a type of kidney failure triggered by severe liver disease, and for spontaneous bacterial peritonitis, a dangerous infection of abdominal fluid that occurs in cirrhosis patients.
In kidney disease, albumin is sometimes combined with diuretics to help patients whose kidneys have stopped responding to diuretics alone, particularly in severe nephrotic syndrome where the body loses massive amounts of protein through urine.
Platelet-Rich Plasma in Orthopedics
Platelet-rich plasma (PRP) takes a different approach: instead of using donor plasma, it concentrates a patient’s own blood. A small blood draw is spun in a centrifuge to separate out a layer rich in platelets, which release growth factors that stimulate tissue repair. The concentrated solution is then injected directly into the injured area.
PRP is most commonly used for chronic tendon injuries like tennis elbow and jumper’s knee, conditions notorious for slow healing. The growth factors in PRP may shorten recovery time and reduce pain. Surgeons also use PRP after procedures on muscles, tendons, and ligaments to speed post-operative healing. PRP was originally developed for jaw and plastic surgery recovery before expanding into sports medicine.
PRP injections are sometimes marketed as an anti-aging skin treatment, but evidence for reducing wrinkles is limited. There is better-supported evidence for PRP’s role in encouraging hair growth in certain types of hair loss.
How Plasma Becomes Medicine
Turning raw plasma into usable therapies is a complex, months-long manufacturing process. Donated plasma is first pooled, then separated through a series of steps that exploit differences in how proteins behave at various temperatures, alcohol concentrations, and acidity levels. This process, called fractionation, yields crude protein fractions that are further purified using chromatography to isolate individual products like clotting factors, immunoglobulins, and albumin.
Safety is built into every stage. Viral inactivation methods include pasteurization (heating protein solutions at 60°C for 10 hours), solvent-detergent treatment that destroys the outer coating of viruses, and dry-heat treatment where freeze-dried products are held at 80°C for three days. These layered precautions mean the risk of transmitting infections through modern plasma products is extremely low.
The final products are filtered, filled into vials or bags, and in many cases freeze-dried so they can be stored at room temperature and reconstituted at the point of care. From a single pool of plasma, manufacturers can extract albumin, multiple types of immunoglobulin, several clotting factors, and specialty proteins like alpha-1 antitrypsin (used to treat a genetic form of lung disease), making plasma one of the most efficiently utilized biological materials in medicine.